Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.

Abstract

These data suggest that active MAPK is a marker of breast cancer metastasis and has a role in the metastatic process. However, active MAPK is unlikely to be a marker of endocrine sensitivity or involved in de novo tamoxifen resistance.